GSK Gsk Plc

TIDMGSK

RNS Number : 9138W

GlaxoSmithKline PLC

29 April 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4R(1)(a) I give details of changes in the notional interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR'), who acquired Ordinary Shares and American Depositary Shares ('ADSs'), at a price of 1502.00 pence per Ordinary Share and $42.64 per ADS, following the re-investment of dividends paid to Shareholders on 14 April 2016, on Ordinary Shares and ADSs held in the GlaxoSmithKline 2009 Deferred Annual Bonus Plan.

 
 
   Director/PDMR          Number of Ordinary     Number of Ordinary 
                          Shares acquired        Shares acquired 
                          under the personal     under the matching 
                          contribution           element of the 
                          element of the         plan (GSK contribution) 
                          plan 
---------------------  ---------------------  -------------------------- 
 
   Sir Andrew 
   Witty                      3,883.790                 3,883.790 
---------------------  ---------------------  -------------------------- 
 
   Mr S Dingemans             2,089.773                 2,089.773 
---------------------  ---------------------  -------------------------- 
 
   Mr R G Connor               858.228                   858.228 
---------------------  ---------------------  -------------------------- 
 
   Mr N Hirons                 548.422                   548.422 
---------------------  ---------------------  -------------------------- 
 
   Mr S A Hussain             1,556.838                 1,556.838 
---------------------  ---------------------  -------------------------- 
 
   Mr D S Redfern             1,077.470                 1,077.470 
---------------------  ---------------------  -------------------------- 
 
   Ms C Thomas                1,271.298                 1,271.298 
---------------------  ---------------------  -------------------------- 
 
   Mr P C Thomson             460.665                   460.665 
---------------------  ---------------------  -------------------------- 
 
   Dr P J T Vallance          2,084.049                 2,084.049 
---------------------  ---------------------  -------------------------- 
 
   Ms E Walmsley              1,506.621                 1,506.621 
---------------------  ---------------------  -------------------------- 
 
 
 
   Director/PDMR      Number of ADSs     Number of ADSs 
                      acquired under     acquired under 
                      the personal       the matching 
                      contribution       element of the 
                      element of the     plan 
                      plan               (GSK contribution) 
-----------------  -----------------  --------------------- 
 
   Dr M M Slaoui        1,543.193            1,543.193 
-----------------  -----------------  --------------------- 
 
   Mr D E Troy           846.539              846.539 
-----------------  -----------------  --------------------- 
 

GlaxoSmithKline plc ('GSK') was advised of these allocations on 28 April 2016.

V A Whyte

Company Secretary

29 April 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHQKLFLQZFLBBL

(END) Dow Jones Newswires

April 29, 2016 12:23 ET (16:23 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024

Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024